2025 annual financial data
Wave Life Sciences 2025 Operating margin
Wave Life Sciences 2025 operating margin with verified reported values.
Direct answer
Operating margin was -504.09%.
Operating income was -215,383,000 USD and net income was -204,378,000 USD.
Operating cash flow was -187,493,000 USD.
Get free Wave Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 42,727,000 USD
- Operating income
- -215,383,000 USD
- Net income
- -204,378,000 USD
- Operating cash flow
- -187,493,000 USD